# Lexaria Bioscience (LEXX) — Overview

LEXX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/lexx

## Price

Last close $2.99 on Oct 15, 2026. 52-week range $2.77 – $20.10.

## Company profile

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $194,000.00 |
| Revenue (quarter) | $0.00 |
| Revenue growth (year over year) | -100.00% |
| Gross profit (trailing twelve months) | $194,000.00 |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$7.7M |
| Net income (quarter) | −$2.0M |
| Net income growth (year over year) | 47.42% |
| Net margin | -3989.92% |
| Return on equity | -150.28% |
| EPS (trailing twelve months) | −$3.28 |
| Book value per share | $2.87 |
| P/E (trailing twelve months) | — |
| Price to book | 1.4 |
| Debt to assets | 9.14% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Lexaria Bioscience (LEXX) profitable?

No. Lexaria Bioscience reported a net loss of $7.7M over the trailing twelve months.

### How much revenue does Lexaria Bioscience (LEXX) make?

Lexaria Bioscience generated $194,000.00 in revenue over the trailing twelve months, down 100.00% year over year.

### How do I buy stock in Lexaria Bioscience (LEXX)?

LEXX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).